ストックスクリーナーアプリを入手
3.48
5.14%
0.17
アフターアワーズ：
3.48
前日終値:
$3.31
開ける：
$3.31
24時間の取引高:
96,555
Relative Volume:
0.78
時価総額：
$131.45M
収益：
-
当期純損益:
$-27.66M
株価収益率:
-3.6632
EPS:
-0.95
ネットキャッシュフロー:
$-24.36M
1週間 パフォーマンス:
-1.42%
1か月 パフォーマンス:
-0.85%
6か月 パフォーマンス:
-4.40%
1年 パフォーマンス:
+46.84%
1日の値動き範囲:
$3.30
$3.6049
1週間の範囲:
$3.30
$3.6339
52週間の値動き範囲:
$1.95
$5.885
Genelux Corp Stock (GNLX) Company Profile
名前
Genelux Corp
セクター
電話
805-267-9889
住所
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
GNLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
3.48 | 127.30M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-29 | 開始されました | Guggenheim | Buy |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2023-11-27 | 開始されました | H.C. Wainwright | Buy |
| 2023-09-12 | 開始されました | Maxim Group | Buy |
| 2023-02-15 | 開始されました | The Benchmark Company | Speculative Buy |
Genelux Corp (GNLX) 最新ニュース
S P Trends: What are the risks of holding Genelux CorporationQuarterly Trade Review & AI Enhanced Trading Alerts - khodrobank.com
Genelux Corp. Lowers Stock Option Exercise Prices - TipRanks
What is Genelux Corporation s revenue forecastWeekly Profit Summary & Safe Capital Growth Plans - khodrobank.com
Using flow based indicators on Genelux CorporationJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Can a trend reversal in Genelux Corporation lead to recoveryJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
Full technical analysis of Genelux Corporation stockMarket Growth Report & Reliable Trade Execution Plans - Newser
Tools to monitor Genelux Corporation recovery probabilityTrend Reversal & Expert Approved Momentum Ideas - Newser
Is Genelux Corporation still worth holding after the dipJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Immuno-Oncology Pioneer Genelux Leadership Team Featured at H.C. Wainwright Global Investment Conference - Stock Titan
How to interpret RSI for Genelux Corporation stockJuly 2025 Setups & Verified Momentum Stock Watchlist - Newser
Is a relief rally coming for Genelux Corporation holdersMarket Activity Report & Fast Moving Stock Watchlists - Newser
Is Gores Holdings IX Inc. Equity Warrant exposed to political riskPortfolio Gains Report & Free Weekly Watchlist of Top Performers - خودرو بانک
Oncolytic Virus Cancer Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail
What institutional flow reveals about Genelux CorporationWeekly Investment Recap & Reliable Breakout Forecasts - Newser
Leading vs lagging indicators on Genelux Corporation performancePortfolio Profit Report & Growth Oriented Trade Recommendations - Newser
Genelux Corporation Stock Approaches Key Moving Average2025 Big Picture & Daily Price Action Insights - beatles.ru
Technical analysis overview for Genelux Corporation stockJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Using Bollinger Bands to evaluate Genelux CorporationWeekly Stock Summary & Verified Entry Point Signals - Newser
Genelux Corporation stock prediction for this week2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-08-30 23:56:19 - Newser
Why Genelux Corporation is moving todayMarket Performance Report & Verified Stock Trade Ideas - Newser
Real time scanner hits for Coterra Energy Inc. explainedWeekly Trend Summary & Community Trade Idea Sharing Platform - Newser
Is now a turning point for Genelux Corporation2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Is Genelux Corporation showing signs of accumulationOil Prices & Capital Protection Trade Alerts - Newser
Applying Wyckoff theory to Genelux Corporation stock2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser
What recovery options are there for Genelux CorporationPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
Institutional scanner results for Cohen Circle Acquisition Corp. I Equity WarrantMarket Weekly Review & Daily Volume Surge Signals - Newser
Genelux Corp (GNLX) 財務データ
収益
当期純利益
現金流量
EPS
Genelux Corp (GNLX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zindrick Thomas | President and CEO |
May 12 '25 |
Sale |
2.92 |
10,764 |
31,431 |
191,447 |
| Yu Yong | VP, Clinical Trial Operations |
May 12 '25 |
Sale |
2.92 |
5,579 |
16,291 |
47,640 |
| Cappello Joseph | VP, Pharmaceutical Development |
May 12 '25 |
Sale |
2.92 |
4,737 |
13,832 |
52,266 |
| Smalling Ralph | Head of Regulatory |
May 12 '25 |
Sale |
2.92 |
1,259 |
3,676 |
34,760 |
| Tyree James L | Director |
Dec 30 '24 |
Sale |
2.46 |
3,460 |
8,512 |
45,791 |
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):